CVS GROUP PLC

Director's Dealing • Nov 17, 2025

National Storage Mechanism | Additional information

RNS Number : 8623H

CVS Group plc

17 November 2025

17 November 2025

CVS Group plc

("CVS" or the "Company")

PDMR Dealing

CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 17 November 2025 that Robin Alfonso, Chief Financial Officer of the Company, purchased a total of 870 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.

As a result, Robin Alfonso's total interest in the Company, including all persons closely associated, is now 25,247 Ordinary Shares, representing 0.035% per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc                                                                                                                    via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

Peel Hunt LLP (Nominated Adviser & Broker)                                                              +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

Berenberg (Joint Broker)                                                                                                 +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

Camarco (Financial PR)                                                                                                  [email protected]

Ginny Pulbrook                                                                                                                   +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robin Alfonso

2

Reason for the notification

a)

Position/status

PDMR (CFO)

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.2 pence each

GB00B2863827

b)

Nature of the transaction

On-market purchase

c)

Price(s) and volume(s)

Price(s) - pence	Volume(s)
1,146.99	870

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

17 November 2025

f)

Place of the transaction

London Stock Exchange - AIM (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBLBDBGXBDGUR